The U.S. Food and Drug Administration (FDA) awarded a $75 million multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract to The Lewin Group, Inc. to support the Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics. The contract has a 5-year ordering period and aims to obtain large-scale, longitudinal healthcare data from the United States covering tens of millions of patients, as well as access to full medical charts for patient data review and adjudication.
The Lewin Group, a subsidiary of UnitedHealth Group, will serve as a primary data source provider, such as a health insurer, payer, or provider, to support the FDA's BEST Initiative. The contract is not set-aside and was awarded through a full and open competition under NAICS code 518210 - Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services. The Lewin Group holds several other IDIQ contracts with the Department of Health and Human Services agencies, enabling efficient access to their expertise in health policy research, data analytics, program evaluation, and implementation support.
Generated 9/27/24, 9:10 AM